Abstract:The PIK3 CA gene encodes the p110α protein subunit and is one of the most efficient cancer genes in solid and hematological tumors including hepatocellular carcinoma (HCC). There are currently ongoing therapies against tumors based on PIK3 CA inhibition. Because microRNAs (miRNAs) play an important role in post-transcriptional regulation and are also involved in the inhibition of PIK3 CA expression to suppress cancer cell proliferation, overexpression of tumor-suppressive miRNA is a promising therapeutic approach for HCC therapy. The successful and localized delivery of miRNA overexpression vectors (pre-miRNA plasmids) is very important in improving the therapeutic efficacy of this miRNA therapy strategy. In the study described here, submicron acoustic phase-shifted nanodroplets were used to efficiently deliver pre-miRNA plasmid in vitro and in vivo for HCC therapy under focused ultrasound (US) activation. Briefly, six miRNAs, inhibiting PIK3 CA and downregulated in HCC, were selected through summary and analysis of the currently existing literature data. Quantitative real-time polymerase chain reaction (qRT-PCR), Western blot and cell apoptosis assay revealed that pre-miR-139, -203a, -378a and -422a plasmids among the six miRNA overexpression vectors could suppress growth of the hepatoma cell line SMMC-7721. These four pre-miRNA plasmids were then electrostatically adhered to positively charged lipid-shelled nanodroplets to obtain plasmid-loaded nanodroplets (PLNDs). The PLND-generated microbubbles oscillated and even collapsed under US exposure to release the loaded pre-miRNA plasmids and enhance their cellular uptake through consequent sonoporation, that is, formation of small pores on the cell membrane induced by the mechanical effects of PLND cavitation. Fluorescence microscopy results revealed that PLNDs could effectively deliver the aforementioned four pre-miRNA plasmids into SMMC-7721 cells in vitro under 1.2-MHz 60-cycle sinusoid US exposure with a peak negative pressure >5.5 MPa at a 40-Hz pulse repetition frequency. Plasmid delivery efficiency and cell viability positively correlated with the inertial cavitation dose that was determined mainly by peak negative pressure. Furthermore, PLNDs combined with US were evaluated in vivo to deliver these four pre-miRNAs plasmids and verify their therapeutic efficacy in subcutaneous tumor of the mouse xenograft HCC model. The results revealed that the PLNDs loaded with pre-miR-139 and -378a plasmids could effectively suppress tumor growth after US treatment. Thus, combination of pre-miRNA PLNDs with US activation seems to constitute a potential strategy for HCC therapy.

Transcutaneous Ultrasound-Mediated Nonviral Gene Delivery to the Liver in a Porcine Model

Research of Ultrasound-Mediated Gene Delivery

Ultrasound directs a transposase system for durable hepatic gene delivery in mice

Enhanced Gene Expression of Systemically Administered Plasmid DNA in the Liver with Therapeutic Ultrasound and Microbubbles

In vivo US monitoring of catheter-based vascular delivery of gene microspheres in pigs: feasibility.

Ultrasound-targeted Microbubble Destruction-mediated Gene Delivery Into Canine Livers

Radiofrequency-Enhanced Vascular Gene Transduction and Expression for Intravascular Mr Imaging-Guided Therapy: Feasibility Study in Pigs

Use of Cationic Microbubbles Targeted to P-selectin to Improve Ultrasound-Mediated Gene Transfection of Hvegf165 to the Ischemic Myocardium

Multiparameter Evaluation of in Vivo Gene Delivery Using Ultrasound-Guided, Microbubble-Enhanced Sonoporation.

Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery

Microsphere as a contrast agent/gene vector in ultrasound imaging-based vascular gene delivery

Ultrasound and Liposome Microbubble-Mediated Targeted Gene Transfer to Cardiomyocytes in Vivo Accompanied by Polyethylenimine

Nonviral ultrasound-mediated gene delivery in small and large animal models

Ultrasound- and Liposome Microbubble-Mediated Targeted Gene Transfer to Cardiomyocytes in Vivo Accompanied by Polyethylenimine.

Intrabiliary Radiofrequency Heating-Enhanced Direct Intratumoral GFP/HSV-TK Gene Therapy of Cholangiocarcinoma: A Preclinical Study on Mice and Pigs

In Vivo Distribution and Gene Expression of Genetically Modified Hepatocytes after Intrasplenic Transplantation

Enhanced Gene Delivery by Ultrasound and Contrast Agent: Experimental Study

Nanobubble Mediated Gene Delivery in Conjunction With a Hand-Held Ultrasound Scanner

Combined Ultrasound-Targeted Microbubble Destruction and Polyethylenimine-Mediated Plasmid Dna Delivery to the Rat Retina: Enhanced Efficiency and Accelerated Expression

Ultrasound-Mediated Gene Therapy of Hepatocellular Carcinoma Using Pre-microRNA Plasmid-Loaded Nanodroplets

Safe Procedure for Efficient Hydrodynamic Gene Transfer to Isolated Porcine Liver in Transplantation